Last reviewed · How we verify

sevoflurane-sufentanil balanced

Konkuk University Medical Center · FDA-approved active Small molecule

A balanced anesthetic combination that pairs sevoflurane (volatile anesthetic) with sufentanil (opioid) to produce general anesthesia through CNS depression and analgesia.

A balanced anesthetic combination that pairs sevoflurane (volatile anesthetic) with sufentanil (opioid) to produce general anesthesia through CNS depression and analgesia. Used for General anesthesia for surgical procedures.

At a glance

Generic namesevoflurane-sufentanil balanced
SponsorKonkuk University Medical Center
Drug classBalanced anesthetic combination
TargetGABA receptors (sevoflurane); mu-opioid receptors (sufentanil)
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhaseFDA-approved

Mechanism of action

Sevoflurane is an inhaled volatile anesthetic that depresses CNS activity and reduces consciousness, while sufentanil is a potent synthetic opioid agonist at mu-opioid receptors that provides analgesia and enhances sedation. Together, they create a balanced anesthetic technique that reduces the required dose of each agent while maintaining hemodynamic stability and providing both hypnosis and pain relief during surgery.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: